These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9676113

  • 1. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
    Katz N, Esik O, Füzy M, Gundy S.
    Orv Hetil; 1998 Jun 21; 139(25):1521-6. PubMed ID: 9676113
    [Abstract] [Full Text] [Related]

  • 2. Cytogenetic study of radiation burden in thyroid disease patients treated with external irradiation or radioiodine.
    Gundy S, Katz N, Füzy M, Esik O.
    Mutat Res; 1996 Jun 10; 360(2):107-13. PubMed ID: 8649463
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaillard N, Parmentier C.
    J Nucl Med; 1996 Nov 10; 37(11):1860-4. PubMed ID: 8917193
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S.
    J Nucl Med; 2005 Feb 10; 46(2):261-6. PubMed ID: 15695785
    [Abstract] [Full Text] [Related]

  • 7. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
    Arndt D, Mehnert WH, Franke WG, Woller P, Laude G, Rockel A, Waller M.
    Strahlenther Onkol; 1994 Jul 10; 170(7):408-14. PubMed ID: 8052940
    [Abstract] [Full Text] [Related]

  • 8. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens FH, Huysmans DA.
    J Nucl Med; 2004 Apr 10; 45(4):626-33. PubMed ID: 15073259
    [Abstract] [Full Text] [Related]

  • 9. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.
    M'Kacher R, Schlumberger M, Légal JD, Violot D, Béron-Gaillard N, Gaussen A, Parmentier C.
    J Nucl Med; 1998 May 10; 39(5):825-9. PubMed ID: 9591584
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP, Schlumberger M, Rubino C, Ricard M, Labbé M, Ceccarelli C, Schvartz C, Henri-Amar M, Bardet S, de Vathaire F.
    J Nucl Med; 2008 May 10; 49(5):845-52. PubMed ID: 18413399
    [Abstract] [Full Text] [Related]

  • 11. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV, Osborne R, Ahn E, Avitia S, Juillard G.
    Ear Nose Throat J; 2009 Jul 10; 88(7):E01. PubMed ID: 19623515
    [Abstract] [Full Text] [Related]

  • 12. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
    Baugnet-Mahieu L, Lemaire M, Léonard ED, Léonard A, Gerber GB.
    Radiat Res; 1994 Dec 10; 140(3):429-31. PubMed ID: 7972697
    [Abstract] [Full Text] [Related]

  • 13. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R, Légal JD, Schlumberger M, Aubert B, Beron-Gaillard N, Gaussen A, Parmentier C.
    J Nucl Med; 1997 Mar 10; 38(3):377-80. PubMed ID: 9074522
    [Abstract] [Full Text] [Related]

  • 14. Detection of short-term chromosomal damage due to therapeutic 131I exposure in patients with thyroid cancer.
    Hernández-Jardines A, Molina B, del Castillo V, Papadakis M, Rivera T, Azorín J, Herrera LA, Yokoyama E, Frías S.
    Rev Invest Clin; 2010 Mar 10; 62(1):31-8. PubMed ID: 20415057
    [Abstract] [Full Text] [Related]

  • 15. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B, Handkiewicz-Junak D, Wloch J.
    Endocr Relat Cancer; 2005 Dec 10; 12(4):773-803. PubMed ID: 16322322
    [Abstract] [Full Text] [Related]

  • 16. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M, Slevin NJ, Sykes AJ, Swindell R, Yap BK.
    Radiother Oncol; 2008 Oct 10; 89(1):105-13. PubMed ID: 18579244
    [Abstract] [Full Text] [Related]

  • 17. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
    Huysmans DA, Buijs WC, van de Ven MT, van den Broek WJ, Kloppenborg PW, Hermus AR, Corstens FH.
    J Nucl Med; 1996 Dec 10; 37(12):2072-9. PubMed ID: 8970537
    [Abstract] [Full Text] [Related]

  • 18. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F.
    Endocr Relat Cancer; 2005 Mar 10; 12(1):49-64. PubMed ID: 15788638
    [Abstract] [Full Text] [Related]

  • 19. [Radiobiologic basis for using 131I to treat patients with thyroid cancer].
    Suwiński R, Gawkowska-Suwińska M.
    Wiad Lek; 2001 Mar 10; 54 Suppl 1():266-77. PubMed ID: 12182035
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.